Page 241 - Veterinary Laser Therapy in Small Animal Practice

References 227

near-infrared light treatment. J Comp Neurol, 2010. to the forehead: a pilot study of 10 patients with major
518(1): pp. 25–40. depression and anxiety. Behav Brain Funct, 2009. 5: p. 46.
388. Oron, A., et al. Low-level laser therapy applied 402. de la Torre, J.C. Treating cognitive impairment with
transcranially to mice following traumatic brain injury transcranial low level laser therapy. J Photochem Photobiol
significantly reduces long-term neurological deficits. J B, 2017. 168: pp. 149–55.
Neurotrauma, 2007. 24(4): pp. 651–6. 403. Myakishev-Rempel, M., et al. A preliminary study of
389. Wu, Q., et al. Low-level laser therapy for closed- the safety of red light phototherapy of tissues harboring
head traumatic brain injury in mice: effect of different cancer. Photomed Laser Surg, 2012. 30(9): pp. 551–8.
wavelengths. Lasers Surg Med, 2012. 44(3): pp. 218–26. 404. de C. Monteiro, J.S., et al. Influence of laser
390. Xuan, W., et al. Low-level laser therapy for traumatic phototherapy (λ660 nm) on the outcome of oral chemical
brain injury in mice increases brain derived neurotrophic carcinogenesis on the hamster cheek pouch model:
factor (BDNF) and synaptogenesis. J Biophotonics, 2015. histological study. Photomed Laser Surg, 2011. 29(11): pp.
8(6): pp. 502–11. 741–5.
391. Xuan, W., L. Huang, and M.R. Hamblin. Repeated 405. Renno, A.C., et al. The effects of laser irradiation
transcranial low-level laser therapy for traumatic brain on osteoblast and osteosarcoma cell proliferation and
injury in mice: biphasic dose response and long-term differentiation in vitro. Photomed Laser Surg, 2007. 25(4):
treatment outcome. J Biophotonics, 2016. 9(11–12): pp. pp. 275–80.
1263–72. 406. Al-Watban, F.A. and B.L. Andres. Laser
392. Naeser, M.A., et al. Improved cognitive function after biomodulation of normal and neoplastic cells. Lasers Med
transcranial, light-emitting diode treatments in chronic, Sci, 2012. 27(5): pp. 1039–43.
traumatic brain injury: two case reports. Photomed Laser 407. Werneck, C.E., et al. Laser light is capable of inducing
Surg, 2011. 29(5): pp. 351–8. proliferation of carcinoma cells in culture: a spectroscopic
393. Leung, M.C., et al. Treatment of experimentally in vitro study. Photomed Laser Surg, 2005. 23(3): pp.
induced transient cerebral ischemia with low energy laser 300–3.
inhibits nitric oxide synthase activity and up-regulates the 408. Kiro, N.E., M.R. Hamblin, and H. Abrahamse.
expression of transforming growth factor-beta 1. Lasers Photobiomodulation of breast and cervical cancer stem
Surg Med, 2002. 31(4): pp. 283–8. cells using low-intensity laser irradiation. Tumour Biol,
394. Peplow, P.V. Neuroimmunomodulatory effects of 2017. 39(6): p. 1010428317706913.
transcranial laser therapy combined with intravenous tPA 409. Zecha, J.A., et al. Low-level laser therapy/
administration for acute cerebral ischemic injury. Neural photobiomodulation in the management of side effects of
Regen Res, 2015. 10(8): pp. 1186–90. chemoradiation therapy in head and neck cancer: part 2:
395. Lampl, Y., et al. Infrared laser therapy for ischemic proposed applications and treatment protocols. Support
stroke: a new treatment strategy: results of the Care Cancer, 2016. 24(6): pp. 2793–805.
NeuroThera Effectiveness and Safety Trial-1 (NEST-1). 410. Fife, D., et al. A randomized, controlled, double-blind
Stroke, 2007. 38(6): pp. 1843–9. study of light emitting diode photomodulation for the
396. Zivin, J.A., et al. Effectiveness and safety of prevention of radiation dermatitis in patients with breast
transcranial laser therapy for acute ischemic stroke. cancer. Dermatol Surg, 2010. 36(12): pp. 1921–7.
Stroke, 2009. 40(4): pp. 1359–64. 411. Censabella, S., et al. Photobiomodulation for the
397. Huisa, B.N., et al. Transcranial laser therapy for acute management of radiation dermatitis: the DERMIS trial, a
ischemic stroke: a pooled analysis of NEST-1 and NEST-2. pilot study of MLS® laser therapy in breast cancer patients.
Int J Stroke, 2013. 8(5): pp. 315–20. Support Care Cancer, 2016. 24(9): pp. 3925–33.
398. Kasner, S.E., et al. Transcranial laser therapy and 412. E Lima, M.T., et al. Low-level laser therapy in
infarct volume. Stroke, 2013. 44(7): pp. 2025–7. secondary lymphedema after breast cancer: systematic
399. Hacke, W., et al. Transcranial laser therapy in acute review. Lasers Med Sci, 2014. 29(3): pp. 1289–95.
stroke treatment: results of neurothera effectiveness and 413. Vaupel, P. and M. Hockel. Blood supply, oxygenation
safety trial 3, a phase III clinical end point device trial. status and metabolic micromilieu of breast cancers:
Stroke, 2014. 45(11): pp. 3187–93. characterization and therapeutic relevance. Int J Oncol,
400. Barrett, D.W. and F. Gonzalez-Lima. Transcranial 2000. 17(5): pp. 869–79.
infrared laser stimulation produces beneficial cognitive 414. Ottaviani, G., et al. Laser therapy inhibits tumor
and emotional effects in humans. Neuroscience, 2013. 230: growth in mice by promoting immune surveillance
pp. 13–23. and vessel normalization. EBioMedicine, 2016. 11: pp.
401. Schiffer, F., et al. Psychological benefits 2 and 4 165–72.
weeks after a single treatment with near infrared light 415. Azevedo, L.H., et al. Evaluation of low intensity laser

REDONDO PRINT (4-COL BLEED).indd 227 08/08/2019 09:51